Abstract-Occupational exposure to plutonium is generally monitored through analysis of urine samples. Typically, plutonium is separated from the sample and other actinides, and the concentration is determined using alpha spectroscopy. Current methods for separations and analysis are lengthy and require long count times. A new method for monitoring occupational exposure levels of plutonium has been developed, which requires fewer steps and overall less time than the alpha spectroscopy method. In this method, the urine is acidified, and a 239 Pu internal standard is added. The urine is digested in a microwave oven, and plutonium is separated using an Eichrom TRU Resin column. The plutonium is eluted, and the eluant is injected directly into the Inductively Coupled Plasma-Mass Spectrometer (ICP-MS). Compared to a direct "dilute and shoot" method, a 30-fold improvement in sensitivity is achieved. This method was validated by analyzing several batches of spiked samples. Based on these analyses, a combined standard uncertainty plot, which relates uncertainty to concentration, was produced. The MDA 95 was calculated to be 7.0 Â 10
INTRODUCTION
THE BIOASSAY Laboratory (BLAB) at Lawrence Livermore National Laboratory (LLNL) provides full radioisotopic analyses services for various biological samples in support of the LLNL Internal Dosimetry Program. The methods used should be highly sensitive, provide a rapid turnaround time, and use minimal amounts of reagents. Ideal procedures should also lower costs and minimize wastes. The BLAB at LLNL was tasked to develop a method for determining 242 Pu in urine samples.
Plutonium-242 is commonly used as a radiochemical tracer in the analysis of plutonium isotopes by alpha spectroscopy. This isotope of plutonium has a long half-life (3.733 Â 10 5 y) and is an alpha-emitter. Plutonium in urine can be determined by the classic co-precipitation, anionexchange separation, electroplating, and alpha counting methods (Kumar et al. 2010) . However, such classic methods are time consuming, requiring many tedious steps and multiple days of alpha counting, in particular for alpha emitters with long half-lives.
Inductively coupled plasma mass spectrometry (ICP-MS) measures the number of atoms in a sample and does not depend on the radioactive decay of the isotope as in alpha spectroscopy. ICP-MS may also have a lower detection limit than alpha spectroscopy when analyzing radionuclides with long half-lives. ICP-MS is therefore ideal for the determination of radionuclides with long half-lives or low specific activity (Kurosaki et al. 2013) . Methods known as "dilute and shoot" have previously been developed to analyze radionuclides in urine samples and are currently in use at LLNL for routine monitoring of uranium isotopes.** Dilute and shoot methods require small aliquots of the sample of interest to be diluted and then directly analyzed by ICP-MS. A simple dilute and shoot method using ICP-MS is much less time consuming and less expensive. Currently, the BLAB's ICP-MS is not sensitive enough to achieve the detection limits required by the LLNL Dosimetry Program for plutonium isotopes using a dilute and shoot method. Thus it requires radiochemical pre-concentration of the urine sample prior to analysis by ICP-MS. Pu is added as an internal standard. As long as a consistent amount is added to each sample, the concentration does not need to be traceable to NIST. Ultra-pure nitric acid (ULTREX II Ultrapure Reagent; J.T. Baker, Avantor Performance Materials, Inc. Center Valley, PA, USA) and ammonium bi-oxalate (prepared from the High Purity Grade Oxalic acid & Ammonium Oxalate; AMRESCO LLC, Solon, OH, USA) were used throughout the procedure. The remaining chemicals used for the procedure were of analytical grade. TRU resin cartridges (Eichrom Technologies LLC, Lisle, IL, USA) and a vacuum box (Eichrom Technologies LLC) were used for the plutonium separations. The sample rack for the vacuum box was designed and fabricated at LLNL to hold 15 mL centrifuge tubes, which can be directly placed into the ICP-MS auto-sampler rack. Samples were analyzed using a Perkin Elmer (Perkin Elmer Waltham, MA, USA) ELAN DRCe ICP-MS. A Savillex (Savillex, Eden Prairie, MN, USA) C-Flow 400 D PFA (perfluouroalkoxy alkane) concentric nebulizer was used to reduce the memory effects and to handle the hydrofluoric acid also used to suppress the memory effects of plutonium. A microwave oven (Microwave Accelerated Reaction System; MARS, CEM Analytical, Matthews, NC, USA) was used to digest the samples.
EXPERIMENTAL

Chemical procedure
This procedure consists of sample acidification, microwave digestion and plutonium separations followed by ICP-MS analysis as shown in Fig. 1 . Two liters of acidified urine (2%, Ultra-pure nitric acid) was used for all analyses. Aliquots of 30 mL of the urine were transferred into 50-mL centrifuge tubes. Two drops of octanol were added to each sample to prevent the sample from excessive foaming while adding nitric acid and heating in the microwave digester. Ultra-pure nitric acid (5.5 mL) and 239 Pu (100 mL,
) internal standard were added. Each sample was spiked with known amounts of 242 Pu as specified in the experimental plan. The samples were mixed, placed in the microwave rotor, and then positioned in the microwave oven. The temperature of the microwave oven was ramped up to 80°C over the course of 30 min and then held at that temperature for 45 min. Microwave digestion eliminates organic interferences in urine and also facilitates equilibrium of the 239 Pu internal standard and the 242 Pu isotopes in the sample. The samples were allowed to cool to ambient temperature and then removed from the microwave. If the sample volume was less than 30 mL as a result of some evaporation occurring during microwave digestion, then the volume was adjusted by addition of deionized water. The oxidation states of 239 Pu and 242 Pu were adjusted to the tetravalent oxidation state by adding ferrous sulfate (1 mL of freshly prepared 0.5 M ferrous sulfate).
The TRU resin cartridge was set up on the vacuum box. The waste collection inner liner insert was placed in the vacuum box. The cartridge was conditioned using 10 mL of 3 M nitric acid. The digested urine sample was then loaded onto the cartridge as shown in Fig. 2 . The sample tube was rinsed with 3 mL of 3 M nitric acid, and the rinse was loaded onto the cartridge. The cartridge was then rinsed with 11 mL of 3 M nitric acid. The waste liner insert was removed from the vacuum box, and a holder with a 15 mL centrifuge tube was inserted in the vacuum box. The plutonium was eluted from the cartridge into the 15 mL centrifuge tube with 10 mL of 0.075 M ammonium bi-oxalate. The 15 mL centrifuge tube was removed once all 10 mL of the ammonium bioxalate had eluted from the cartridge. The sample was capped, mixed and set aside for analysis by ICP-MS.
Measurement
The samples were analyzed using the ICP-MS and the associated Elan software. The operational parameters for the analysis procedure are listed in Table 1 . Preliminary experiments indicated that plutonium has a memory effect that can affect following samples. To reduce the memory effect, a PFA nebulizer was used, and a rinse solution containing 5% nitric acid and 0.005 M hydrofluoric acid was used between samples.
A set of four 242
Pu calibration standards covering a range from 3.0 Â 10 −6 mg L −1 to 5.0 Â 10 −4 mg L −1 and a calibration blank were prepared for each run. The calibration standards consist of 9.8 mL of 0.075 M ammonium bi-oxalate spiked with the 242 Pu standard (0.1 mL). Plutonium-239 (0.1 mL) was added as an internal standard with a final concentration of 0.01 mg L −1
. The response for the calibration blank, consisting of 0.075 M ammonium bi-oxalate, was subtracted from each standard/sample in the run.
Sample sets
Each sample set consisted of eight samples spiked with increasing concentrations of 242 Pu as shown in Table 2 . The Minimum Testing Level (MTL) for plutonium by isotopic mass is 4 pg L −1 for radiobioassay performance testing (ANSI 2011). The upper bound for performance testing is 20 times the MTL. Sample 8 was a laboratory control sample (LCS) spiked at a concentration mid-range between the test samples. Plutonium-239 was added as an internal standard such that the final eluted solution contains 0.01 mg L −1 of 239 Pu. A total of eight independent replicate sample sets were analyzed.
MDA
Results from the eight urine blanks analyzed were used to determine the Critical Level (Lc 95 ) and minimum (USEPA 2012) . The MDL is defined as the minimum concentration of a substance that can be measured and reported with 99% confidence. The Lc 95 is consistent with this definition at the 95% confidence level.
where t n−1,0.95 is the Student's t factor at the 95% confidence limit for n replicate values (1.895 for eight replicates), and S is the standard deviation of the n replicate values.
Instrument performance checks
The instrument performance checks were standards included in the sample runs to ensure the instrument was functioning properly throughout the entire run. These samples Pu. The run would have been stopped if the results for these samples were not within the acceptable criteria, and corrective actions would have been required in order to proceed with a sample run.
RESULTS AND DISCUSSION
Method performance results
Results for the eight replicate runs, including the percent bias (%Bias) and the percent relative standard deviation (%RSD), are shown in Table 3 . The MDA 95 and the Lc 95 for the method were calculated using the standard deviation (S) of observed 242 Pu concentration of the eight urine blank samples. The MDA 95 was calculated to be 7.0 Â 10 −7 mg L −1
, and the Lc 95 was calculated to be 3.5 Â 10 −7 mg L −1
.
Measurement of uncertainty
The standard deviations (S) of the results for the eight independent measurements at each of the eight different 242 Pu concentrations covering the range of expected 242 Pu concentrations were used to estimate the Type A uncertainties (Fig. 3) . These uncertainties include uncertainties due to sample preparation (i.e., volumetric uncertainties), calibration (i.e., each batch was run with a separate set of calibration standards) and measurement (i.e., instrument instability). The Type B uncertainty includes the uncertainty of the ) with the lowest relative uncertainty (3.6%), addition of the Type B uncertainty increases the relative uncertainty from 3.6% to 3.8%. Thus to simplify calculations, the Type B uncertainty is not included in the uncertainty budget. The standard deviation of each set of eight replicates was plotted against the associated the uncertainty (u C ):
Method comparison
Routine determination of plutonium in urine by coprecipitation, anion-exchange separation and electroplating at LLNL takes about a week for one person to complete, followed by a 2-d count time using alpha spectroscopy. The urine sample (~1.4 L) is acidified, a tracer is added, and then the entire sample volume is heated and stirred for an hour to digest some of the organic material and to equilibrate the solution. Actinides are separated from the solution by co-precipitation, the precipitate is wet-ashed and dissolved in 8M nitric acid, and the plutonium is separated using an anion-exchange column. The plutonium is then electrodeposited onto a stainless steel disc and analyzed by alpha spectroscopy. A 2-d count time is required to meet the required detection limits.
The proposed method presented in this paper drastically reduces the sample preparation and analysis time and requires smaller sample volumes compared to the current routine determination of plutonium in urine used by LLNL. Time-consuming digestion, co-precipitation, wet-ashing and electrodeposition steps are eliminated. Column separations are performed under vacuum, reducing the time for this step. Samples are prepared for analysis by acidification, addition of an internal standard, digestion in a microwave digester system, and plutonium is separated using TRU cartridges and a vacuum box. The samples are directly analyzed in the ICP-MS after plutonium is eluted from the columns. Analysis of 20 samples per batch can thus be completed in less than two working days by one person using the proposed method, as opposed to the routine method, which requires a 2-d counting period in addition to the sample preparation time. The proposed method requires a sample volume of 30 mL for analysis as opposed to the routine LLNL method, which requires the entire sample. The proposed method provides an MDA that is similar to that of the alpha spectroscopy method (MDA of 0.006 dpm L −1 compared to the MDA of 0.007 dpm L −1 for the current routine LLNL method).
Possible interferences
When analyzing extremely low levels of plutonium by ICP-MS, interferences from natural uranium can affect the method accuracy. These interferences include peak tailing from 238 U and the formation of 238 UH þ polyatomic ions. Urine naturally contains small levels of natural 238 U. Proper tuning of the mass spectrometer can eliminate the uranium peak tailing. The resolution of the mass spectrometer on the ICP-MS was tuned to 0.7 amu (peak width measured at 10% of peak height). Preliminary test data indicate that both 238 U peak tailing and 238 UH þ polyatomic ions formation do 14.12 14.51 0.5 Â MTL 2.00 Â 10 −6 ± 3.63 Â 10 not produce a significant interference on the 239 Pu tracer at the levels of uranium commonly found in urine.
Memory effects occur when the plutonium in a sample is partially retained in the spray chamber and nebulizer. The plutonium that is retained can elute during the analysis of the following samples, affecting the accuracy of measurements for low levels of plutonium. A PFA nebulizer and spray chamber and a rinse solution of 5% ultrapure nitric acid with 0.005 M hydrofluoric acid were used to decrease the memory effect.
CONCLUSION
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